Notice of Investor Presentation

In brief · summary, not quotable

4basebio PLC has announced an investor presentation scheduled for 29 June 2026 at 17:00 BST, accessible via the Investor Meet Company platform. The presentation, featuring the Chief Executive Officer and Chief Commercial Officer, will not disclose any new material information. Existing and potential shareholders are invited to attend, with questions able to be submitted in advance by 09:00 BST on 28 June 2026 or during the live event.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes

16 June

2026

– 4basebio PLC (AIM: 4BB),a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces that it will provide a live investor presentation on 29 June 2026.

Amy Walker, Chief Executive Officer, and Christine Wolosin, Chief Commercial Officer, will

provide a live presentation via the Investor Meet Company platform on 29 June 2026 at 17:00 BST. No new material information will be disclosed during the event.

Investors can sign up to Investor Meet Company for free and add to meet 4basebio PLC via:

Investors who already follow 4basebio PLC on the Investor Meet Company platform will automatically be invited.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.